Asia-Pacific Americas Africa Europe Middle East

BEXIMCO PHARMACEUTICAL LTD

Company Profile:

BEXIMCO PHARMACEUTICAL LTD Company Profile:

BEXIMCO PHARMACEUTICAL LTD is a factory.

Beximco Pharmaceuticals Ltd is a leading pharmaceutical manufacturer based in Bangladesh. Established in 1976, it commenced operations in 1985 and has since grown to become one of the largest and most respected pharmaceutical companies in the country. The company manufactures and markets a wide range of pharmaceutical formulations and active pharmaceutical ingredients (APIs).

Its product portfolio covers various therapeutic areas, including antimicrobials, analgesics, anti-diabetics, cardiovascular drugs, respiratory drugs, and many others, available in different dosage forms such as tablets, capsules, liquids, injectables, and dry powder inhalers.

Beximco Pharma operates state-of-the-art manufacturing facilities that comply with stringent international regulatory standards, including those of the US FDA, UK MHRA, EU GMP, and TGA Australia. This commitment to quality and compliance has enabled the company to export its products to over 50 countries worldwide, including developed markets in Europe and Australia, establishing itself as a significant global player in the pharmaceutical industry.

The company is also actively involved in research and development, focusing on new drug formulations and delivery systems to address unmet medical needs. It is listed on the Dhaka Stock Exchange and the London Stock Exchange's AIM market, reflecting its robust financial standing and corporate governance.

Enterprise Products

Beximco Pharmaceutical Ltd. manufactures and sells a wide array of pharmaceutical products spanning numerous therapeutic categories. These include:

A. Cardiovascular System

Medications for conditions such as hypertension, heart failure, angina, arrhythmias, and dyslipidemia.

B. Anti-infectives

A broad range of antibiotics, antifungals, antivirals, and antiparasitic drugs to combat various infections.

C. Central Nervous System

Products addressing neurological and psychiatric disorders including depression, anxiety, epilepsy, Parkinson's disease, and pain management.

D. Gastrointestinal System

Medications for acid reflux, peptic ulcers, irritable bowel syndrome, constipation, diarrhea, and other digestive disorders.

E. Respiratory System

Treatments for asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, and other respiratory ailments.

F. Pain and Inflammation

Analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), and muscle relaxants for acute and chronic pain relief and inflammatory conditions.

G. Antidiabetic

Oral hypoglycemic agents, insulin preparations, and other drugs for the management of type 1 and type 2 diabetes.

H. Vitamins and Minerals

A variety of nutritional supplements, multi-vitamins, and mineral preparations.

I. Dermatology

Topical creams, ointments, lotions, and other formulations for various skin conditions such as eczema, fungal infections, and acne.

J. Oncology

Anti-cancer drugs and supportive care medications for the treatment of various types of cancer.

K. Urology

Products for benign prostatic hyperplasia (BPH), erectile dysfunction, and other urinary tract conditions.

L. Women's Health

Medications related to gynecological conditions, hormonal therapies, and reproductive health.

M. Ophthalmology

Eye drops and ointments for treating various eye conditions including infections, glaucoma, and allergic conjunctivitis.

N. Other therapeutic areas also include products for musculoskeletal disorders, immunology, and rare diseases, covering a comprehensive spectrum of healthcare needs.

Business Registration Information:

Manager:

Mr. Nazmul Hassan MP (Managing Director) Mr. Rabbur Reza (CEO & Director)

Phone:

+880-2-58150861-63

E-mail:

info@beximcopharma.com

Official Website:
Address:

Beximco Pharmaceuticals Ltd. 19 Dhanmondi R/A, Road No. 7, Dhaka-1205, Bangladesh.

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.